1 / 63

Percent of patients 47.8+ (52.0) 45.5 to <47.8 43.9 to <45.5 42.2 to <43.9 below 42.2 (40.5)

Primary Cause of Kidney Failure in new ESRD patients at initiation, by ethnicity figure 2.1, 1997-2000 combined. Percent of new patients with diabetes as the primary cause of renal failure figure 2.2, 1999-2000 combined, by HSA, unadjusted. Percent of patients 47.8+ (52.0) 45.5 to <47.8

cparman
Download Presentation

Percent of patients 47.8+ (52.0) 45.5 to <47.8 43.9 to <45.5 42.2 to <43.9 below 42.2 (40.5)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Primary Cause of Kidney Failure in new ESRD patients at initiation, by ethnicityfigure 2.1, 1997-2000 combined

  2. Percent of new patients with diabetes as the primary cause of renal failurefigure 2.2, 1999-2000 combined, by HSA, unadjusted Percent of patients 47.8+ (52.0) 45.5 to <47.8 43.9 to <45.5 42.2 to <43.9 below 42.2 (40.5)

  3. Cardiovascular comorbidity at initiation:diabeticsfigure 2.3, 2000, by HSA, unadjusted Percent of patients 43.8+ (48.7) 39.7 to <43.8 36.8 to <39.7 33.5 to <36.8 below 33.5 (29.8)

  4. Cardiovascular comorbidity at initiation:non-diabeticsfigure 2.3, 2000, by HSA, unadjusted Percent of patients 34.0+ (37.2) 30.1 to <34.0 26.2 to <30.1 24.0 to <26.2 below 24.0 (21.8)

  5. Trends in cardiovascular comorb. from inpatient hospitalization diagnosis codes, in patients surviving one-year after ESRD figure 2.4, incident ESRD patients

  6. Trends in cardiovascular comorb. developed in the two years prior to dialysis, patients 67 years & olderfigure 2.5, incident ESRD patients

  7. Trends in the number of comorbid conditions at initiationfigure 2.6, incident ESRD patients

  8. Trends in the occurrence of diabetes as a primary or secondary complication, by race/ethnicity figure 2.7, incident ESRD patients All White Black Percent of patients

  9. Trends in the occurrence of diabetes as a primary or secondary complication, by race/ethnicity figure 2.7, incident ESRD patients Native American Asian Hispanic Percent of patients

  10. % of pts at initiation with serum albumin < test’s lower limit, by age& genderfigure 2.8, incident ESRD patients Age Gender

  11. % of pts at initiation with serum albumin < test’s lower limit, by race, & primary diagnosisfigure 2.8, incident ESRD patients (cont.) Race Primary diagnosis Percent of patients

  12. Geographic variations in the % of patients at initiation with albumin levels below the test’s lower limit: 1995figure 2.9, incident ESRD patients, by HSA, unadjusted Percent of patients 64.3+ (66.1) 62.9 to <64.3 58.5 to 62.9 56.8 to <58.5 below 56.8 (55.7)

  13. Geographic variations in the % of patients at initiation with albumin levels below the test’s lower limit: 2000figure 2.9, incident ESRD patients, by HSA, unadjusted Percent of patients 64.3+ (65.2) 62.9 to <64.3 58.5 to <62.9 56.8 to <58.5 below 56.8 (NA)

  14. Geographic variations in the % of pts at initiation with allbumin levels < the test’s lower limit: % change 1995-2000figure 2.9, incident ESRD patients, by HSA, unadjusted Percent change 14.2+ (16.2) 11.9 to <14.2 10.2 to 11.9 9.0 to <10.2 below 9.0 (7.8)

  15. Trends in EPO use prior to initiation, by age & genderfigure 2.10, incident ESRD patients

  16. Trends in EPO use prior to initiation, by race/ethnicity & genderfigure 2.11, incident ESRD patients

  17. Trends in mean hemoglobin at initiation, by EPO treatmentfigure 2.12, incident ESRD patients

  18. Geographic variations in the percent of patients receiving EPO prior to initiation, by race: allfigure 2.13, 1999-2000 combined, incident ESRD patients, by HSA, unadjusted Percent of patients 34.7+ (41.8) 28.8 to <34.7 24.2 to <28.8 19.6 to <24.2 below 19.6 (16.4)

  19. Geographic variations in the percent of patients receiving EPO prior to initiation, by race: whitefigure 2.13, 1999-2000 combined, incident ESRD patients, by HSA, unadjusted Percent of patients 34.7+ (41.3) 28.8 to <34.7 24.2 to <28.8 19.6 to <24.2 below 19.6 (17.1)

  20. Geographic variations in the % of pts receiving EPO prior to initiation, by race: non-whitefigure 2.13, 1999-2000 combined, incident ESRD patients, by HSA, unadjusted Percent of patients 34.7+ (41.2) 28.8 to <34.7 24.2 to <28.8 19.6 to <24.2 below 19.6 (16.4)

  21. Trends in hemoglobin level from the Medical Evidence Form 2728 at initiationfigure 2.14, incident ESRD patients

  22. Trends in mean hemoglobin at initiation, by age & genderfigure 2.15, incident ESRD patients

  23. Trends in mean hemoglobin at initiation, by race/ethnicity & genderfigure 2.16, incident ESRD patients

  24. Trends in mean hemoglobin at initiation, by modalityfigure 2.17, incident ESRD patients

  25. Geographic variations in mean hemoglobin at initiation: allfigure 2.18, 1999-2000 combined, incident ESRD patients, by HSA, unadjusted Mean hemoglobin (g/dl) 10.0+ (10.1) 9.8 to <10.0 9.7 to <9.8 9.6 to <9.7 below 9.6 (9.5)

  26. Geographic variations in mean hemoglobin at initiation: whitefigure 2.18, 1999-2000 combined, incident ESRD patients, by HSA, unadjusted Mean hemoglobin (g/dl) 10.0+ (10.2) 9.8 to <10.0 9.7 to <9.8 9.6 to <9.7 below 9.6 (9.4)

  27. Geographic variations in mean hemoglobin at initiation: non-whitefigure 2.18, 1999-2000 combined, incident ESRD patients, by HSA, unadjusted Mean hemoglobin (g/dl) 10.0+ (10.3) 9.8 to <10.0 9.7 to <9.8 9.6 to <9.7 below 9.6 (9.5)

  28. Geographic variations in mean BUN at initiation: 2000figure 2.19, incident ESRD patients, by HSA, unadjusted Mean BUN (mg/dl) 89.1+ (92.0) 87.4 to <89.1 85.9 to <87.4 84.4 to <85.9 below 84.4 (81.5)

  29. Geographic variations in mean BUN at initiation, percent change : 1995-2000figure 2.19, incident ESRD patients, by HSA, unadjusted Percent change -5.3+ (-3.2) -6.5 to <-5.3 -7.9 to <-6.5 -9.7 to <-7.9 below -9.7 (-13.0)

  30. Trends in mean BUN at initiation, by age & race/ethnicityfigure 2.20, incident ESRD patients

  31. Geographic variations in mean serum creatinine at initiationfigure 2.21, incident ESRD patients, by HSA, unadjusted Serum creatinine (mg/dl) 7.59+ (7.94) 7.31 to <7.59 7.00 to <7.31 6.72 to <7.00 below 6.72 (6.49)

  32. Geographic variations in mean serum creatinine at initiation, % change: 1995-2000 figure 2.21, incident ESRD patients, by HSA, unadjusted Percent change -11.3+ (-8.5) -14.3 to <-11.3 -16.7 to <-14.3 -19.5 to <-16.7 below -19.5 (-21.9)

  33. Trends in mean serum creatinine at initiation, by age & race/ethnicityfigure 2.22, incident ESRD patients

  34. Geographic variations in mean eGFR at initiation: 2000figure 2.23, incident ESRD patients, by HSA, unadjusted eGFR (ml/min) 8.91+ (9.25) 8.57 to <8.91 8.38 to <8.57 8.22 to <8.38 below 8.22 (8.03))

  35. Geographic variations in mean eGFR at initiation, % change: 1995-2000figure 2.23, incident ESRD patients, by HSA, unadjusted Percent change 22.8+ (27.4) 20.0 to <22.8 18.0 to <20.0 15.9 to <18.0 below 15.9 (13.5)

  36. Trends in mean eGFR at initiation, by age & race/ethnicityfigure 2.24

  37. Geographic variations in mean BMI at initiation: 2000figure 2.25, incident ESRD patients, by HSA, unadjusted BMI (kg/m2) 27.0+ (27.2) 26.9 to <27.0 26.8 to <26.9 26.7 to <26.8 below 26.7 (26.5)

  38. Geographic variations in mean BMI at initiation, % change: 1995-2000figure 2.25, incident ESRD patients, by HSA, unadjusted Percent change 7.15+ (9.69) 5.73 to <7.15 4.57 to <5.73 3.05 to <4.57 below 3.05 (0.53)

  39. Trends in mean BMI at initiation, by age & race/ethnicityfigure 2.26, incident ESRD patients

  40. BMI distribution in Patients with a history of cardiovascular disease & strokefigure 2.27 by age, race and ethnicity

  41. BMI distribution in Patients with a history of cardiovascular disease & stroke figure 2.28 by age, race and ethnicity

  42. Differences in eGFR at initiation, by age, race/ethnicity, diabetic status, & genderfigure 2.29 Diabetics

  43. Differences in eGFR at initiation, by age, race/ethnicity, diabetic status, & genderfigure 2.29 (con.t) Non-diabetics

  44. Differences in eGFR at initiation, by pre-ESRD hospital days, age, & gender, patients 67 & olderfigure 2.30

  45. Differences in eGFR at initiation, by Charlson score, & age, patients 67 & olderfigure 2.31

  46. Differences in eGFR at initiation, by Charlson score, & gender, patients 67 & olderfigure 2.31 (cont.)

  47. Event curves for first hospitalization in the first year of ESRD, by eGFR at initiationfigure 2.32, incident dialysis patients, 1998-1999 combined

  48. Event curves for survival in the first year of ESRD, by eGFR at initiationfigure 2.33, incident dialysis patients, 1998-1999 combined

  49. Percent survival, by eGFR at initiation & racefigure 2.34, incident dialysis patients, 1998-1999 combined

  50. Percents receiving EPO before initiation, by race/ethnicity & insurance coveragefigure 2.35, incident ESRD patients, 2000 Percent of patients All W B NA A H All W B NA A H All W B NA A H All W B NA A H

More Related